Literature DB >> 11584964

Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?

D Shibata1, J J Lewis, D H Leung, M F Brennan.   

Abstract

Complete surgical resection is the most effective modality for the treatment of retroperitoneal sarcomas. Previous studies of all types of retroperitoneal sarcomas have not shown a survival benefit of incomplete resection over no resection. Because death often occurs as a result of local progression in retroperitoneal liposarcomas (RPLS), it is possible that incomplete resection may be beneficial in this histologic type. In this study we have sought to determine the clinical outcomes in patients with incompletely resected and unresected RPLS with the aim of defining patients who may benefit from palliative resection. From a prospective clinical database 55 patients with incompletely resected (n = 43) or unresected (n = 12) RPLS were identified between 1982 and 1999. Statistical analyses were performed using the log-rank test and Kaplan-Meier estimates with disease-specific survival as the primary end point. Variables studied included age, gender, recurrent versus primary disease, tumor grade, and tumor size. The patient population consisted of 34 men and 21 women with a mean age of 61 +/- 14 (SD) years. The median time to death was 10 months (range 1 to 83 months) with a median followup of 12 months (range 1 to 60 months) for survivors. Partial resection was an independent factor for increased survival as compared with exploration or biopsy only (median survival 26 versus 4 months, p < 0.0001). Of patients who received incomplete resections, locally recurrent presentation (n = 19) versus primary disease (n = 24) was a negative prognostic variable (median survival 17 versus 46 months, p = 0.009). Successful palliation of symptoms was achieved in 24 of 32 patients (75%) with preoperative symptoms. In select patients with unresectable RPLS, incomplete surgical resection can provide prolongation in survival and successful symptom palliation. Most likely to benefit are those patients presenting with primary tumors, suggesting that surgical resection should be attempted in the majority of patients.

Entities:  

Mesh:

Year:  2001        PMID: 11584964     DOI: 10.1016/s1072-7515(01)01024-9

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  30 in total

1.  Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.

Authors:  Alexandra M Koenig; Matthias Reeh; Christoph M Burdelski; Claudia Wengert; Karim A Gawad; Jakob R Izbicki; Maximilian Bockhorn
Journal:  Langenbecks Arch Surg       Date:  2012-03-10       Impact factor: 3.445

2.  [Therapeutic management of intra-abdominal and retroperitoneal soft tissue sarcomas].

Authors:  S Wong; M F Brennan
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

3.  Retroperitoneal sarcomas- a challenging problem.

Authors:  Vijay Kumar; Sanjeev Misra; Arun Chaturvedi
Journal:  Indian J Surg Oncol       Date:  2012-05-30

4.  Recurrent Retroperitoneal Liposarcoma: a Case Report and Literature Review.

Authors:  D Ramu; Suraj Manjunath; G Anuradh
Journal:  Indian J Surg Oncol       Date:  2018-05-19

Review 5.  [Intra-abdominal and retroperitoneal sarcomas].

Authors:  J Kirchberg; J Weitz
Journal:  Chirurg       Date:  2016-03       Impact factor: 0.955

Review 6.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

7.  Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.

Authors:  James O Park; Li-Xuan Qin; Francesco P Prete; Cristina Antonescu; Murray F Brennan; Samuel Singer
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

8.  Incidental finding of renal cell carcinoma in recurrent retroperitoneal liposarcoma.

Authors:  J M L Williamson; T C König; R Canelo
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

9.  Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.

Authors:  Mitri Khoury; Geok Choo Sim; Michiko Harao; Laszlo Radvanyi; Behrang Amini; Robert S Benjamin; Peter W T Pisters; Raphael E Pollock; William W Tseng
Journal:  BMJ Case Rep       Date:  2015-07-08

Review 10.  Giant retroperitoneal liposarcoma with mixed histological pattern: a rare presentation and literature review.

Authors:  Nikolaos S Salemis; Evangelos Tsiambas; Andreas Karameris; Efstathios Tsohataridis
Journal:  J Gastrointest Cancer       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.